本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

8.39
-0.1900-2.21%
盤後8.400.0100+0.12%16:58 EDT
成交量:93.42萬
成交額:782.99萬
市值:7.41億
市盈率:-2.64
高:8.57
開:8.52
低:8.27
收:8.58
52周最高:12.49
52周最低:5.41
股本:8,832.98萬
流通股本:6,398.56萬
量比:0.75
換手率:1.46%
股息:- -
股息率:- -
每股收益(TTM):-3.1784
每股收益(LYR):-3.1784
淨資產收益率:-94.82%
總資產收益率:-25.33%
市淨率:4.26
市盈率(LYR):-2.64

資料載入中...

2026/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/01/29

重要事件披露

Form 8-K - Current report
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans